These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 35354153)
1. Association of Serum Triglycerides and Renal Outcomes among 1.6 Million US Veterans. Soohoo M; Hashemi L; Hsiung JT; Moradi H; Budoff MJ; Kovesdy CP; Kalantar-Zadeh K; Streja E Nephron; 2022; 146(5):457-468. PubMed ID: 35354153 [TBL] [Abstract][Full Text] [Related]
2. Triglycerides and Renal Outcomes According to Albuminuria and in Consideration of Other Metabolic Syndrome Components in Diabetic US Veterans. Rizk JG; Hsiung JT; Arif Y; Hashemi L; Sumida K; Kovesdy CP; Kalantar-Zadeh K; Streja E Am J Nephrol; 2023; 54(1-2):14-24. PubMed ID: 36889289 [TBL] [Abstract][Full Text] [Related]
3. Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD. Bowe B; Xie Y; Xian H; Li T; Al-Aly Z Clin J Am Soc Nephrol; 2017 Apr; 12(4):603-613. PubMed ID: 28348030 [TBL] [Abstract][Full Text] [Related]
4. Serum triglycerides and mortality risk across stages of chronic kidney disease in 2 million U.S. veterans. Soohoo M; Moradi H; Obi Y; Kovesdy CP; Kalantar-Zadeh K; Streja E J Clin Lipidol; 2019; 13(5):744-753.e15. PubMed ID: 31562050 [TBL] [Abstract][Full Text] [Related]
5. Risk of end-stage renal disease from chronic kidney disease defined by decreased glomerular filtration rate in type 1 diabetes: A comparison with type 2 diabetes and the effect of metabolic syndrome. Lee YB; Han K; Kim B; Jun JE; Lee SE; Ahn J; Kim G; Jin SM; Kim JH Diabetes Metab Res Rev; 2019 Nov; 35(8):e3197. PubMed ID: 31222888 [TBL] [Abstract][Full Text] [Related]
6. Risk of Atherosclerotic Cardiovascular Disease and Nonatherosclerotic Cardiovascular Disease Hospitalizations for Triglycerides Across Chronic Kidney Disease Stages Among 2.9 Million US Veterans. Soohoo M; Hashemi L; Hsiung JT; Moradi H; Budoff MJ; Kovesdy CP; Kalantar-Zadeh K; Streja E J Am Heart Assoc; 2021 Dec; 10(23):e022988. PubMed ID: 34729994 [TBL] [Abstract][Full Text] [Related]
7. Abrupt Decline in Kidney Function Before Initiating Hemodialysis and All-Cause Mortality: The Chronic Renal Insufficiency Cohort (CRIC) Study. Hsu RK; Chai B; Roy JA; Anderson AH; Bansal N; Feldman HI; Go AS; He J; Horwitz EJ; Kusek JW; Lash JP; Ojo A; Sondheimer JH; Townsend RR; Zhan M; Hsu CY; Am J Kidney Dis; 2016 Aug; 68(2):193-202. PubMed ID: 26830447 [TBL] [Abstract][Full Text] [Related]
8. Short-term change in kidney function and risk of end-stage renal disease. Turin TC; Coresh J; Tonelli M; Stevens PE; de Jong PE; Farmer CK; Matsushita K; Hemmelgarn BR Nephrol Dial Transplant; 2012 Oct; 27(10):3835-43. PubMed ID: 22764191 [TBL] [Abstract][Full Text] [Related]
9. Associations Between Weight Loss, Kidney Function Decline, and Risk of ESRD in the Chronic Kidney Disease in Children (CKiD) Cohort Study. Ku E; Kopple JD; McCulloch CE; Warady BA; Furth SL; Mak RH; Grimes BA; Mitsnefes M Am J Kidney Dis; 2018 May; 71(5):648-656. PubMed ID: 29132947 [TBL] [Abstract][Full Text] [Related]
10. Pain and Kidney Function Decline and Mortality: A Cohort Study of US Veterans. Ravel V; Ahmadi SF; Streja E; Sosnov JA; Kovesdy CP; Kalantar-Zadeh K; Chen JLT Am J Kidney Dis; 2016 Aug; 68(2):240-246. PubMed ID: 27108099 [TBL] [Abstract][Full Text] [Related]
11. Neutrophil-to-lymphocyte ratio and incident end-stage renal disease in Chinese patients with chronic kidney disease: results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE). Yuan Q; Wang J; Peng Z; Zhou Q; Xiao X; Xie Y; Wang W; Huang L; Tang W; Sun D; Zhang L; Wang F; Zhao MH; Tao L; He K; Xu H; J Transl Med; 2019 Mar; 17(1):86. PubMed ID: 30876475 [TBL] [Abstract][Full Text] [Related]
12. Receipt of Nephrology Care and Clinical Outcomes Among Veterans With Advanced CKD. Fung E; Chang TI; Chertow GM; Thomas IC; Asch SM; Kurella Tamura M Am J Kidney Dis; 2017 Nov; 70(5):705-714. PubMed ID: 28811048 [TBL] [Abstract][Full Text] [Related]
13. Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study. Chinnadurai R; Flanagan E; Jayson GC; Kalra PA BMC Nephrol; 2019 Oct; 20(1):380. PubMed ID: 31640599 [TBL] [Abstract][Full Text] [Related]
14. Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease. Nacak H; van Diepen M; Qureshi AR; Carrero JJ; Stijnen T; Dekker FW; Evans M Nephrol Dial Transplant; 2015 Dec; 30(12):2039-45. PubMed ID: 26185050 [TBL] [Abstract][Full Text] [Related]
15. First-year estimated glomerular filtration rate variability after pre-end-stage renal disease program enrollment and adverse outcomes of chronic kidney disease. Tsai CW; Huang HC; Chiang HY; Chung CW; Chiu HT; Liang CC; Yu T; Kuo CC Nephrol Dial Transplant; 2019 Dec; 34(12):2066-2078. PubMed ID: 29982714 [TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome is a predictor of decreased renal function among community-dwelling middle-aged and elderly Japanese. Kawamoto R; Akase T; Ninomiya D; Kumagi T; Kikuchi A Int Urol Nephrol; 2019 Dec; 51(12):2285-2294. PubMed ID: 31642000 [TBL] [Abstract][Full Text] [Related]
17. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease. Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165 [TBL] [Abstract][Full Text] [Related]